Altern Ther Health Med. 2023 Nov;29(8):110-120.
To evaluate the current evidence of the effectiveness of dry needling in patients with chronic low back pain (LBP).
PubMed, Medline, ScienceDirect, Web of Science, CINAHL and PEDro databases were searched until 2020.
Randomised controlled trials (RCTs) that used dry needling as the main treatment and which included participants diagnosed with chronic LBP.
Two reviewers independently screened articles, scored methodologic quality, and extracted data. The primary outcomes were pain intensity and functional disability at post-intervention and follow-up.
A total of 8 RCTs involving 414 patients were included in the meta-analysis. All trials examined the efficacy of DN in patients with chronic LBP. Results suggested that compared with other treatments, dry needling combined was more effective in alleviating the pain intensity of LBP post-intervention (standardised mean difference [SMD], -0.42; 95% confidence interval [CI], -0.79 to -0.05; P = .03) and at short- term (SMD -0.99, 95% CI -1.61 to -0.37, P = .002).
Current evidence showed that dry needling, especially if associated with other therapies, could be recommended to relieve the pain intensity of LBP at post-intervention and at short-term follow up. There is no evidence that dry needling alone or in combination improves disability at post-immediate or at short-term follow up.
This review was registered on PROSPERO (PROSPERO CRD42020215781) and was aligned with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for reporting systematic reviews that evaluate healthcare interventions.
评估干针疗法治疗慢性下背痛(LBP)患者的有效性的现有证据。
检索 PubMed、Medline、ScienceDirect、Web of Science、CINAHL 和 PEDro 数据库,检索时间截至 2020 年。
使用干针治疗作为主要治疗方法并纳入诊断为慢性 LBP 的患者的随机对照试验(RCT)。
两位评审员独立筛选文章、评分方法学质量并提取数据。主要结局指标为干预后和随访时的疼痛强度和功能障碍。
共纳入 8 项 RCT,涉及 414 例患者。所有试验均检查了 DN 在慢性 LBP 患者中的疗效。结果表明,与其他治疗方法相比,干针联合治疗在干预后(标准化均数差 [SMD],-0.42;95%置信区间 [CI],-0.79 至 -0.05;P =.03)和短期(SMD -0.99,95% CI -1.61 至 -0.37,P =.002)更能有效缓解 LBP 的疼痛强度。
现有证据表明,干针治疗,特别是如果与其他治疗方法联合使用,可推荐用于缓解干预后和短期随访时的 LBP 疼痛强度。没有证据表明干针单独或联合使用可改善即时或短期随访时的残疾程度。
本综述已在 PROSPERO(PROSPERO CRD42020215781)上注册,并符合系统评价和荟萃分析报告系统评价的首选报告项目(PRISMA)指南,以评估医疗保健干预措施。